<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>renal outcomes &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/renal-outcomes/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 05 Jan 2026 09:34:12 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>renal outcomes &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Incretin Modulation Revolutionizes Diabetes, Heart, and Kidney Health</title>
		<link>https://bioengineer.org/incretin-modulation-revolutionizes-diabetes-heart-and-kidney-health/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 05 Jan 2026 09:33:58 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cardiovascular health in diabetes]]></category>
		<category><![CDATA[Diabetes Management]]></category>
		<category><![CDATA[diyabet tedavisi]]></category>
		<category><![CDATA[GLP-1 receptor agonists]]></category>
		<category><![CDATA[GLP-1 reseptör agonistleri** **Açıklama:** 1. **incretin modülasyonu:** Makalenin temel konusu ve anahtar mekanizması. 2. **diyabet tedavisi]]></category>
		<category><![CDATA[incretin therapy]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **incretin modülasyonu]]></category>
		<category><![CDATA[kardiyovasküler sonuçlar]]></category>
		<category><![CDATA[renal outcomes]]></category>
		<category><![CDATA[renal sonuçlar]]></category>
		<guid isPermaLink="false">https://bioengineer.org/incretin-modulation-revolutionizes-diabetes-heart-and-kidney-health/</guid>

					<description><![CDATA[Recent advancements in diabetes therapy have taken a significant turn as researchers delve into incretin modulation, revealing its profound potential to alter cardiovascular and renal outcomes. In a groundbreaking study led by Miramontes-González and colleagues, the focus on incretin-based therapies highlights how they are poised to reshape the landscape of diabetes management, ensuring not only [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">313677</post-id>	</item>
	</channel>
</rss>
